Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Saved in:
| Title: | Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer. |
|---|---|
| Authors: | Lee HJ; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Kim YA; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Sim CK; Lab of Molecular Immunology and Medicine, Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Korea., Heo SH; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Song IH; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Park HS; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Park SY; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Bang WS; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Park IA; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Lee M; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Lee JH; Lab of Molecular Immunology and Medicine, Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Korea., Cho YS; Lab of Molecular Immunology and Medicine, Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Korea., Chang S; Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Korea., Jung J; Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Korea., Kim J; Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Lee SB; Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Kim SY; R&D Center, GNSBio Co. Ltd., Gyeonggi-do, Korea., Lee MS; Lab of Molecular Immunology and Medicine, Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Korea., Gong G; Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. |
| Source: | Oncotarget [Oncotarget] 2017 Dec 06; Vol. 8 (69), pp. 113345-113359. Date of Electronic Publication: 2017 Dec 06 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
